The post Edgen’s “Smart Portfolio” Brings Portfolio-Native Multi-Agent Reasoning to Asset Portfolios appeared on BitcoinEthereumNews.com. Hong Kong, Hong Kong, October 15th, 2025, FinanceWire Edgen, a market intelligence platform for equities and digital assets, today announced “Intelligent Portfolios”, a Personalized AI Investment Assistant that runs continuous portfolio-native diagnostics, letter-grade ratings, and personalized recommendations on investor-defined lists of assets. The system produces a single, explainable, cross-asset view that updates as markets move. With this update, users will leverage a guidance model to coordinate specialist agents for technicals, fundamentals, macro, and momentum on lists of assets they own or are eyeing. These agents verify real-time context before synthesizing a one list-level brief with tables, charts, and a final letter score for each asset. The interface centers on the rest of Edgen’s interfaces, including 360° Reports, News, and other agents, with per-asset sparklines, grade badges, and a Full Report action for deeper analysis. “Investors don’t need more apps or streams of data to see what’s going on in markets. Bookmarking an asset is just the first step,” said Sean Tao, the CEO & Co-Founder of Edgen. “They need reasoning applied to the set of assets they actually hold or watch. Smart Portfolios maintains that diagnosis continuously and explains the next step.” Assets can be added from any section of the Edgen platform. Each list, portfolio, or portfolio becomes a live analytical surface that the system diagnoses continuously.” Portfolios (up to 30 assets per list) include Market, 360° Reports, and News views, which combine market statistics, a synthesized letter-grade assessment with rationale, and list-filtered headlines. Additional agentic interfaces are currently in development to augment list-level analysis, like local price pivots, comparisons, and more. “A multi-agent architecture sits behind the scenes,” said Holly Hao, CTO of Edgen. “Specialist agents retrieve verified inputs across stocks and crypto in parallel, and the guidance model assembles a single answer for the portfolio or watchlist.”… The post Edgen’s “Smart Portfolio” Brings Portfolio-Native Multi-Agent Reasoning to Asset Portfolios appeared on BitcoinEthereumNews.com. Hong Kong, Hong Kong, October 15th, 2025, FinanceWire Edgen, a market intelligence platform for equities and digital assets, today announced “Intelligent Portfolios”, a Personalized AI Investment Assistant that runs continuous portfolio-native diagnostics, letter-grade ratings, and personalized recommendations on investor-defined lists of assets. The system produces a single, explainable, cross-asset view that updates as markets move. With this update, users will leverage a guidance model to coordinate specialist agents for technicals, fundamentals, macro, and momentum on lists of assets they own or are eyeing. These agents verify real-time context before synthesizing a one list-level brief with tables, charts, and a final letter score for each asset. The interface centers on the rest of Edgen’s interfaces, including 360° Reports, News, and other agents, with per-asset sparklines, grade badges, and a Full Report action for deeper analysis. “Investors don’t need more apps or streams of data to see what’s going on in markets. Bookmarking an asset is just the first step,” said Sean Tao, the CEO & Co-Founder of Edgen. “They need reasoning applied to the set of assets they actually hold or watch. Smart Portfolios maintains that diagnosis continuously and explains the next step.” Assets can be added from any section of the Edgen platform. Each list, portfolio, or portfolio becomes a live analytical surface that the system diagnoses continuously.” Portfolios (up to 30 assets per list) include Market, 360° Reports, and News views, which combine market statistics, a synthesized letter-grade assessment with rationale, and list-filtered headlines. Additional agentic interfaces are currently in development to augment list-level analysis, like local price pivots, comparisons, and more. “A multi-agent architecture sits behind the scenes,” said Holly Hao, CTO of Edgen. “Specialist agents retrieve verified inputs across stocks and crypto in parallel, and the guidance model assembles a single answer for the portfolio or watchlist.”…

Edgen’s “Smart Portfolio” Brings Portfolio-Native Multi-Agent Reasoning to Asset Portfolios

Hong Kong, Hong Kong, October 15th, 2025, FinanceWire

Edgen, a market intelligence platform for equities and digital assets, today announced “Intelligent Portfolios”, a Personalized AI Investment Assistant that runs continuous portfolio-native diagnostics, letter-grade ratings, and personalized recommendations on investor-defined lists of assets. The system produces a single, explainable, cross-asset view that updates as markets move.

With this update, users will leverage a guidance model to coordinate specialist agents for technicals, fundamentals, macro, and momentum on lists of assets they own or are eyeing. These agents verify real-time context before synthesizing a one list-level brief with tables, charts, and a final letter score for each asset. The interface centers on the rest of Edgen’s interfaces, including 360° Reports, News, and other agents, with per-asset sparklines, grade badges, and a Full Report action for deeper analysis.

Assets can be added from any section of the Edgen platform. Each list, portfolio, or portfolio becomes a live analytical surface that the system diagnoses continuously.”

Portfolios (up to 30 assets per list) include Market, 360° Reports, and News views, which combine market statistics, a synthesized letter-grade assessment with rationale, and list-filtered headlines. Additional agentic interfaces are currently in development to augment list-level analysis, like local price pivots, comparisons, and more.

Over time, as a user’s bookmarks evolve, Edgen begins to recognize their style, risk appetite, and curiosity arcs, as well as sector affinities, and adjusts its suggestions accordingly. The platform pivots from a passive tool to a responsive companion.

Smart Portfolios is designed to be the foundation of portfolio-native reasoning across Edgen. Upcoming releases will introduce more agentic interfaces, reflecting a steady cadence of product development that deepens the intelligence layer and personalizes each investor’s basket of assets, thereby closing the intelligence gap in markets that are increasingly fast and complex.

About Edgen

Edgen is an AI Co-Pilot for investors, bringing stocks and crypto together into one unified intelligence layer. It addresses market data overload and information asymmetries by orchestrating hundreds of expert tools, agents, and data sources into a single interface, turning fragmentation into clear, actionable insights for investors of all backgrounds. Edgen integrates AI assistants, real-time social sentiment, and blockchain analytics to automate analyses, optimize portfolios, and identify market entry points with ease.

Backed by leading investors such as Framework Ventures and North Island Ventures, Edgen’s team brings together former Wall Street quantitative traders and core Web3 protocol developers, building the cognitive infrastructure for next-generation open finance.

Website: https://www.edgen.tech/ 

X/Twitter: https://x.com/EdgenTech 

Media contact: [email protected] 

Contact

Kelvin Yeo
[email protected]

Source: https://finbold.com/from-tracking-to-thinking-edgens-smart-portfolio-brings-portfolio-native-multi-agent-reasoning-to-asset-portfolios/

Market Opportunity
LayerEdge Logo
LayerEdge Price(EDGEN)
$0.003679
$0.003679$0.003679
+1.23%
USD
LayerEdge (EDGEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26